Neyaz Elahi
Srinagar (NVI): The Kashmir Valley today received 79,000 doses of ‘Covishield’, the COVID-19 vaccine which is manufactured by Pune-based Serum Institute of India (SII).
Divulging information on this, Director Health Services Kashmir, Dr Samir Mattoo said that 79,000 doses of COVID-19 vaccine arrived in Valley today which will be administered to people in Phase wise.
He said that it is a continuous process and more such vaccines will arrive in Valley in the coming days.
“In the first phase, these vaccines will be administered to 60,000 health workers. The drive for administering the vaccine will start at Srinagar on January 16, Mattoo said.
In response to a question, Samir Mattoo further said that COVID affected patients will get this vaccine in Phase 4.
“There will be no shortage of these vaccines in Kashmir Valley. These will be administered to people even in far flung areas like Gurez, Machil, Keran, Tangdhar, Tulail,” he added.
He also informed that Department of Health has already done ground work and mock drills in this regard. These vaccines have been kept at central storage site.
-RJV
